This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Sep 18;354(9183):1033-4.

doi: 10.1016/S0140-6736(05)76641-1.

Stevens-Johnson syndrome and antiepileptics

N Dunn, L Wilton, S Shakir

PMID: 10501393
DOI: 10.1016/S0140-6736(05)76641-1

Comment

Stevens-Johnson syndrome and antiepileptics

N Dunn et al. Lancet. 1999.

. 1999 Sep 18;354(9183):1033-4.

doi: 10.1016/S0140-6736(05)76641-1.

Authors

N Dunn, L Wilton, S Shakir

PMID: 10501393
DOI: 10.1016/S0140-6736(05)76641-1

No abstract available

PubMed Disclaimer

Comment on

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Rzany B, et al. Lancet. 1999 Jun 26;353(9171):2190-4. doi: 10.1016/s0140-6736(98)05418-x. Lancet. 1999. PMID: 10392983

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.